Specialty chemicals group DSM booked net profit of €288m in 2012, down from €814m a year earlier. Group sales were flat at over €9bn.
Operating profit before depreciation was down 16% at €1.1bn.
The company described the results as ‘solid’, given the global economic situation and expects an improvement in operational earnings this year.
In particular, the company’s nutritional activities now account for 70% of operating profit and offer attractive growth prospects, chief executive Feike Sijbesma said in a statement.